Does Dextrose Soybean Oil Electrolytes Lysine Phenylalanine Leuci Interact with Oral Anticoagulants?
CDI records a major classification for Dextrose Soybean Oil Electrolytes Lysine Phenylalanine Leuci and Oral Anticoagulants. The stored summary is: Vitamin K1 in soybean oil component may counteract anticoagulant activity. Monitor laboratory parameters for anticoagulant activity. The mechanism involves vitamin k1 reverses coumarin derivatives' effect by blocking vitamin k1 recycling inhibition. Patients taking both medications should consult their healthcare provider before starting, stopping, or changing the dosage of either drug. This record was extracted from drug labeling through openFDA. NIH/NLM RxNorm is used for drug identities. The summary and severity classification are CDI's processed information, not a verbatim source quotation. Product, route, and patient circumstances matter.
- Severity
- Major
- Dextrose Soybean Oil Electrolytes Lysine Phenylalanine Leuci Class
- Amino Acid
- Management
- Close medical supervision required
- Data Source
- U.S. FDA via OpenFDA
Recorded Mechanism
Vitamin K1 reverses coumarin derivatives' effect by blocking vitamin K1 recycling inhibition
What To Tell Your Doctor or Pharmacist
If you are taking Dextrose Soybean Oil Electrolytes Lysine Phenylalanine Leuci and your doctor is considering prescribing Oral Anticoagulants (or vice versa), make sure to:
- Inform your doctor and pharmacist of all current medications, including over-the-counter drugs and supplements
- Ask whether the benefits of combining these medications outweigh the risks for your specific situation
- Ask what symptoms to watch for that would indicate the interaction is causing problems
- Ask how frequently you should be monitored while these are co-prescribed
- Ask whether any dosage adjustments are needed
- Never stop or change either medication without first consulting your healthcare provider